Psychiatric Adverse Events Associated with Varenicline: An Intensive Postmarketing Prospective Cohort Study in New Zealand

Author： Harrison-Woolrych Mira   Ashton Janelle  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.9, 2011-09, pp. : 763-772

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cardiovascular Events in Patients taking Varenicline: A Case Series from Intensive Postmarketing Surveillance in New Zealand

By Harrison-Woolrych Mira  

Drug Safety, Vol. 35, Iss. 1, 2012-01 ,pp. : 33-43

Adis International

Access to resources Recommend Favorite

Incidence, Preventability, and Impact of Adverse Drug Events (ADEs) and Potential ADEs in Hospitalized Children in New Zealand: A Prospective Observational Cohort Study

By Kunac Desireé L.  

Pediatric Drugs, Vol. 11, Iss. 2, 2009-01 ,pp. : 153-160

Adis International

Access to resources Recommend Favorite

Fatal and Non-Fatal Cardiovascular Events in a General Population Prescribed Sibutramine in New Zealand: A Prospective Cohort Study

By Harrison-Woolrych Mira  

Drug Safety, Vol. 33, Iss. 7, 2010-07 ,pp. : 605-613

Adis International

Access to resources Recommend Favorite

Varenicline and CV events: postmarketing experience in NZ

By  

Reactions Weekly, Vol. 1, Iss. 1383, 2012-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Serious adverse CV events with varenicline

By  

Reactions Weekly, Vol. 1, Iss. 1360, 2011-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite